Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNE.L Regulatory News (HNE)

  • There is currently no data for HNE

Performance is getting back on track

27 Jul 2023 07:15

RNS Number : 3034H
Henderson Eurotrust PLC
27 July 2023
 

London, UK, 27 July 2023

 

Henderson EuroTrust (HNE): Performance is getting back on track.

Henderson EuroTrust's (HNE's) performance is getting back on track as investors have become more focused on company fundamentals rather than macroeconomic factors, and investors' strong preference for value stocks (translating into style headwinds for HNE between Q121 and Q222) has waned recently. The manager (Jamie Ross) is building on HNE's NAV 10-year record of outperformance versus the Europe ex-UK market (10.5% pa versus 9.1% pa respectively), based on a concentrated portfolio of high-quality growth stocks. European equities are very attractively valued and, coupled with the trust's double-digit discount, this should make HNE worthy of consideration.

 

There is scope for the trust to be afforded a higher valuation now its performance is improving, or if investors become less risk-averse. HNE has one of the widest discounts in its sector despite its performance being above average over the last one, five and 10 years.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first company in-market 17 years ago, Edison has more than 100 employees and covers every economic sector. Headquartered in London, Edison also has offices in New York, Sydney and Wellington.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Mel Jenner +44 (0)20 3077 5700 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on: 

LinkedIn www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAXQLFLXDLZBBQ
Date   Source Headline
13th Apr 202312:52 pmRNSNet Asset Value(s)
12th Apr 202311:52 amRNSNet Asset Value(s)
11th Apr 20232:27 pmRNSNet Asset Value(s)
6th Apr 20231:06 pmRNSNet Asset Value(s)
5th Apr 202312:36 pmRNSNet Asset Value(s)
4th Apr 202312:47 pmRNSNet Asset Value(s)
3rd Apr 20234:37 pmRNSNet Asset Value(s)
31st Mar 20231:04 pmRNSDoc re. Half Year Update
31st Mar 202312:49 pmRNSNet Asset Value(s)
30th Mar 202312:12 pmRNSNet Asset Value(s)
29th Mar 202312:04 pmRNSNet Asset Value(s)
28th Mar 202312:30 pmRNSNet Asset Value(s)
27th Mar 20233:08 pmRNSNet Asset Value(s)
24th Mar 202312:31 pmRNSNet Asset Value(s)
23rd Mar 202311:53 amRNSNet Asset Value(s)
22nd Mar 20233:34 pmRNSHalf-year Report
22nd Mar 202312:33 pmRNSNet Asset Value(s)
21st Mar 20233:58 pmRNSMonthly Factsheet as at 28 February 2023
21st Mar 202311:26 amRNSNet Asset Value(s)
20th Mar 20232:44 pmRNSNet Asset Value(s)
17th Mar 202311:51 amRNSNet Asset Value(s)
16th Mar 202312:46 pmRNSNet Asset Value(s)
15th Mar 202312:49 pmRNSNet Asset Value(s)
14th Mar 202311:28 amRNSNet Asset Value(s)
13th Mar 20232:58 pmRNSNet Asset Value(s)
10th Mar 202312:31 pmRNSNet Asset Value(s)
9th Mar 20234:00 pmRNSHolding(s) in Company
9th Mar 202312:46 pmRNSNet Asset Value(s)
8th Mar 202312:47 pmRNSNet Asset Value(s)
7th Mar 202312:08 pmRNSNet Asset Value(s)
6th Mar 20232:04 pmRNSNet Asset Value(s)
3rd Mar 202312:39 pmRNSNet Asset Value(s)
2nd Mar 20231:23 pmRNSNet Asset Value(s)
1st Mar 202311:30 amRNSNet Asset Value(s)
28th Feb 202312:08 pmRNSNet Asset Value(s)
27th Feb 20233:35 pmRNSNet Asset Value(s)
27th Feb 202312:02 pmRNSHolding(s) in Company
24th Feb 202312:35 pmRNSNet Asset Value(s)
23rd Feb 20233:54 pmRNSMonthly Factsheet as at 31 January 2023
23rd Feb 202311:27 amRNSNet Asset Value(s)
22nd Feb 202311:38 amRNSNet Asset Value(s)
21st Feb 202311:23 amRNSNet Asset Value(s)
21st Feb 20238:53 amRNSCompliance with Market Abuse Regulation
20th Feb 20232:42 pmRNSNet Asset Value(s)
17th Feb 202312:57 pmRNSNet Asset Value(s)
16th Feb 202312:40 pmRNSNet Asset Value(s)
15th Feb 202311:52 amRNSNet Asset Value(s)
14th Feb 202311:24 amRNSNet Asset Value(s)
13th Feb 20234:13 pmRNSNet Asset Value(s)
10th Feb 202312:39 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.